Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
Racialized inequities in live birth after cancer: A population-based study of 63,000 female adolescents and young adults with cancer.
Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Health equity in fertility specialty care among cancer survivors
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520834.
View in:
PubMed
subject areas
Biomarkers, Tumor
Female
Humans
Neoadjuvant Therapy
Neoplasm Staging
Precision Medicine
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda